$636,164
＋97.8%
Chief Operating Officer
2024
$583k org
40 hrs/wk
$55k other
--
Chief Operating Officer at Transcelerate Biopharma Inc.
Fiscal year ended December 31, 2024. Published on January 25, 2026.
Total compensation
Allison Cuff Shimooka has been listed as an employee of Transcelerate Biopharma Inc. in Form 990 filings since fiscal year 2023. Total compensation for Allison Cuff Shimooka has increased by 97.8% from 2023 to 2024.